Results 91 to 100 of about 226,340 (313)

The Antidiabetic Potential of Alpha‐Mangostin: A Review of Preclinical and Clinical Evidence

open access: yesAgriFood: Journal of Agricultural Products for Food, EarlyView.
Alpha‐mangostin is a compound from the pericarp of Garcinia mangostana. The antidiabetic effects of alpha‐mangostin include enhancing insulin secretion, improving glucose uptake through GLUT receptor upregulation, reducing oxidative stress and inflammation, promoting wound healing, reducing HbA1C, reducing HOMA‐IR index, and decreased mRNA expressions ...
Oliver Dean John   +4 more
wiley   +1 more source

Effect of aegle Marmelos fruit pulp powder on glycemic status of type 2 diabetic patients

open access: yesIMC Journal of Medical Science, 2013
Plant materials are considered to be attractive potential sources of alternate agents in the prevention and management of type 2 diabetes mellitus (T2DM). Different parts of Aegle marmelos have been claimed to possess anti-glycemic property.
Murshida Aziz   +2 more
doaj  

Glycemic Index and Load of Selected Ethiopian Foods: An Experimental Study

open access: yesJournal of Diabetes Research, 2019
Background. Determining the glycemic index and load of foods has significant impact on meal planning for diabetes. However, there is no data on the glycemic index (GI) and glycemic load (GL) of Ethiopian foods.
Nebiyu Dereje   +4 more
doaj   +1 more source

Glycemic index, glycemic load, and pancreatic cancer risk (Canada) [PDF]

open access: yes, 2004
There is some evidence that plasma insulin and postload plasma glucose may be associated with risk of pancreatic cancer. Glycemic index and glycemic load are measures, which allow the carbohydrate content of individual foods to be classified according to
Meera Jain   +12 more
core   +1 more source

Shared Metabolic–Proteinopathy Axis in Alzheimer's Disease and Parkinson's Disease: Evidence for a Convergent but Not Identical Disease Spectrum

open access: yesAGING MEDICINE, EarlyView.
This review explores the common pathological mechanisms underlying Alzheimer's disease (AD) and Parkinson's disease (PD), with an emphasis on glucose metabolism and insulin resistance. We examine how disruptions in glucose metabolism and insulin resistance influence the onset and advancement of both Alzheimer's disease (AD) and Parkinson's disease (PD).
Shun‐yu Yao   +5 more
wiley   +1 more source

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis

open access: yes, 2015
Karel Kostev,1 Franz W Dippel,2 Wolfgang Rathmann3 1IMS Health, Frankfurt, 2Sanofi-Aventis Deutschland GmbH, Berlin, 3Institute of Biometrics and Epidemiology, German Diabetes Center, Düsseldorf, Germany Background: When target glycated hemoglobin ...
Rathmann W   +5 more
core   +1 more source

Effects of Glycemic Control on Hearing Outcomes in Diabetes Patients With Idiopathic Sudden Sensorineural Hearing Loss

open access: yes, 2021
OBJECTIVE: This study aimed to analyze the effects of glycemic control on the hearing outcomes of type 2 diabetes patients with idiopathic sudden sensorineural hearing loss (ISSHL). METHODS: Type 2 diabetes patients with ISSHL were enrolled. All patients
Jung, Hak Hyun   +9 more
core   +1 more source

Chinese Expert Consensus on the Clinical Application of Finerenone in Geriatric Comorbidities

open access: yesAGING MEDICINE, EarlyView.
Mineralocorticoid receptor (MR) overactivation drives inflammation, oxidative stress, and fibrosis in the heart, kidneys, and vasculature, leading to cardiorenal dysfunction. MR signaling promotes hypertrophy, remodeling, and injury through pathways like oxidative stress and inflammation, resulting in vascular stiffness and progressive organ damage ...
Xiaoming Wang, Cuntai Zhang
wiley   +1 more source

Early Glycemic Control in Critically Ill Emergency Department Patients: Pilot Trial

open access: yesWestern Journal of Emergency Medicine, 2010
Objective: Glycemic control in the critically ill intensive care unit (ICU) patient has been shown to improve morbidity and mortality. We sought to investigate the effect of early glycemic control in critically ill emergency department (ED) patients in a
Cohen, Jason   +5 more
doaj  

Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus

open access: yes, 2018
Lipid-lowering therapy is used very commonly nowadays not only for the optimization of the lipid profile but also to reduce cardiovascular risk. However, some studies have linked the use of certain lipid-lowering agents with an increased risk for ...
Constantine E Kosmas   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy